vs
Compass, Inc.（COMP）与百利高（PRGO）财务数据对比。点击上方公司名可切换其他公司
Compass, Inc.的季度营收约是百利高的1.5倍（$1.7B vs $1.1B），Compass, Inc.净利率更高（-2.5% vs -127.8%，领先125.3%），Compass, Inc.同比增速更快（23.1% vs -2.5%），百利高自由现金流更多（$148.6M vs $42.2M），过去两年Compass, Inc.的营收复合增速更高（27.0% vs 1.3%）
Compass, Inc.是美国主营住宅房产经纪业务的企业，其平台旗下有约3.3万名经纪人，大多为独立合同工，运营Compass、21世纪不动产、科威国际不动产、苏富比国际地产、佳士得国际地产等多个知名房产经纪品牌。
百利高（Perrigo）是一家注册于爱尔兰的非处方仿制药生产商，主打自有品牌OTC药品业务。公司70%的净销售额来自美国医疗市场，为优化税务布局将法定总部设在爱尔兰，该地区销售额仅占总营收的0.6%，2013年曾完成美国历史上第六大企业税收倒置交易。
COMP vs PRGO — 直观对比
营收规模更大
COMP
是对方的1.5倍
$1.1B
营收增速更快
COMP
高出25.7%
-2.5%
净利率更高
COMP
高出125.3%
-127.8%
自由现金流更多
PRGO
多$106.4M
$42.2M
两年增速更快
COMP
近两年复合增速
1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.7B | $1.1B |
| 净利润 | $-42.6M | $-1.4B |
| 毛利率 | — | 32.6% |
| 营业利润率 | -2.5% | -116.0% |
| 净利率 | -2.5% | -127.8% |
| 营收同比 | 23.1% | -2.5% |
| 净利润同比 | -5.2% | -3093.9% |
| 每股收益（稀释后） | $-0.07 | $-10.23 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COMPPRGO
| Q4 25 | $1.7B | $1.1B | ||
| Q3 25 | $1.8B | $1.0B | ||
| Q2 25 | $2.1B | $1.1B | ||
| Q1 25 | $1.4B | $1.0B | ||
| Q4 24 | $1.4B | $1.1B | ||
| Q3 24 | $1.5B | $1.1B | ||
| Q2 24 | $1.7B | $1.1B | ||
| Q1 24 | $1.1B | $1.1B |
净利润COMPPRGO
| Q4 25 | $-42.6M | $-1.4B | ||
| Q3 25 | $-4.6M | $7.5M | ||
| Q2 25 | $39.4M | $-8.4M | ||
| Q1 25 | $-50.7M | $-6.4M | ||
| Q4 24 | $-40.5M | $-44.4M | ||
| Q3 24 | $-1.7M | $-21.0M | ||
| Q2 24 | $20.7M | $-108.4M | ||
| Q1 24 | $-132.9M | $2.0M |
毛利率COMPPRGO
| Q4 25 | — | 32.6% | ||
| Q3 25 | — | 36.1% | ||
| Q2 25 | — | 34.4% | ||
| Q1 25 | — | 37.6% | ||
| Q4 24 | — | 33.9% | ||
| Q3 24 | — | 37.2% | ||
| Q2 24 | — | 37.0% | ||
| Q1 24 | — | 33.1% |
营业利润率COMPPRGO
| Q4 25 | -2.5% | -116.0% | ||
| Q3 25 | -0.4% | 7.0% | ||
| Q2 25 | 1.9% | 4.3% | ||
| Q1 25 | -4.0% | 4.5% | ||
| Q4 24 | -2.9% | 10.0% | ||
| Q3 24 | -0.2% | 7.4% | ||
| Q2 24 | 1.3% | -2.5% | ||
| Q1 24 | -12.5% | -5.1% |
净利率COMPPRGO
| Q4 25 | -2.5% | -127.8% | ||
| Q3 25 | -0.2% | 0.7% | ||
| Q2 25 | 1.9% | -0.8% | ||
| Q1 25 | -3.7% | -0.6% | ||
| Q4 24 | -2.9% | -3.9% | ||
| Q3 24 | -0.1% | -1.9% | ||
| Q2 24 | 1.2% | -10.2% | ||
| Q1 24 | -12.6% | 0.2% |
每股收益（稀释后）COMPPRGO
| Q4 25 | $-0.07 | $-10.23 | ||
| Q3 25 | $-0.01 | $0.05 | ||
| Q2 25 | $0.07 | $-0.06 | ||
| Q1 25 | $-0.09 | $-0.05 | ||
| Q4 24 | $-0.08 | $-0.32 | ||
| Q3 24 | $0.00 | $-0.15 | ||
| Q2 24 | $0.04 | $-0.79 | ||
| Q1 24 | $-0.27 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $199.0M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $782.0M | $2.9B |
| 总资产 | $1.5B | $8.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资COMPPRGO
| Q4 25 | $199.0M | — | ||
| Q3 25 | $170.3M | $432.1M | ||
| Q2 25 | $177.3M | $454.2M | ||
| Q1 25 | $127.0M | $409.9M | ||
| Q4 24 | $223.8M | $558.8M | ||
| Q3 24 | $211.2M | $1.5B | ||
| Q2 24 | $185.8M | $542.8M | ||
| Q1 24 | $165.9M | $658.5M |
股东权益COMPPRGO
| Q4 25 | $782.0M | $2.9B | ||
| Q3 25 | $773.3M | $4.4B | ||
| Q2 25 | $719.9M | $4.5B | ||
| Q1 25 | $635.0M | $4.4B | ||
| Q4 24 | $409.4M | $4.3B | ||
| Q3 24 | $428.0M | $4.6B | ||
| Q2 24 | $398.4M | $4.5B | ||
| Q1 24 | $330.3M | $4.7B |
总资产COMPPRGO
| Q4 25 | $1.5B | $8.5B | ||
| Q3 25 | $1.6B | $10.1B | ||
| Q2 25 | $1.6B | $10.1B | ||
| Q1 25 | $1.5B | $9.8B | ||
| Q4 24 | $1.2B | $9.6B | ||
| Q3 24 | $1.2B | $11.2B | ||
| Q2 24 | $1.2B | $10.4B | ||
| Q1 24 | $1.1B | $10.6B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.3M | $175.4M |
| 自由现金流经营现金流 - 资本支出 | $42.2M | $148.6M |
| 自由现金流率自由现金流/营收 | 2.5% | 13.4% |
| 资本支出强度资本支出/营收 | 0.2% | 2.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $203.3M | $145.1M |
8季度趋势，按日历期对齐
经营现金流COMPPRGO
| Q4 25 | $45.3M | $175.4M | ||
| Q3 25 | $75.5M | $51.7M | ||
| Q2 25 | $72.8M | $75.9M | ||
| Q1 25 | $23.1M | $-64.5M | ||
| Q4 24 | $30.5M | $312.6M | ||
| Q3 24 | $37.4M | $42.2M | ||
| Q2 24 | $45.0M | $9.5M | ||
| Q1 24 | $8.6M | $-1.4M |
自由现金流COMPPRGO
| Q4 25 | $42.2M | $148.6M | ||
| Q3 25 | $73.6M | $29.8M | ||
| Q2 25 | $68.0M | $56.7M | ||
| Q1 25 | $19.5M | $-90.0M | ||
| Q4 24 | $26.7M | $274.9M | ||
| Q3 24 | $32.8M | $15.1M | ||
| Q2 24 | $40.4M | $-18.9M | ||
| Q1 24 | $5.9M | $-26.5M |
自由现金流率COMPPRGO
| Q4 25 | 2.5% | 13.4% | ||
| Q3 25 | 4.0% | 2.9% | ||
| Q2 25 | 3.3% | 5.4% | ||
| Q1 25 | 1.4% | -8.6% | ||
| Q4 24 | 1.9% | 24.2% | ||
| Q3 24 | 2.2% | 1.4% | ||
| Q2 24 | 2.4% | -1.8% | ||
| Q1 24 | 0.6% | -2.4% |
资本支出强度COMPPRGO
| Q4 25 | 0.2% | 2.4% | ||
| Q3 25 | 0.1% | 2.1% | ||
| Q2 25 | 0.2% | 1.8% | ||
| Q1 25 | 0.3% | 2.4% | ||
| Q4 24 | 0.3% | 3.3% | ||
| Q3 24 | 0.3% | 2.5% | ||
| Q2 24 | 0.3% | 2.7% | ||
| Q1 24 | 0.3% | 2.3% |
现金转化率COMPPRGO
| Q4 25 | — | — | ||
| Q3 25 | — | 6.89× | ||
| Q2 25 | 1.85× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.17× | — | ||
| Q1 24 | — | -0.70× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COMP
暂无分部数据
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
